These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 14660097)

  • 1. Assessment of ethnic variation in serum levels of total, complexed and free prostate specific antigen. Comparison of Maori, Pacific Island and New Zealand European populations.
    Gray MA; Delahunt B; Fowles JR; Weinstein P; Cooke RR; Nacey JN
    Pathology; 2003 Dec; 35(6):480-3. PubMed ID: 14660097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific reference ranges for prostate-specific antigen (PSA) in Jordanian patients.
    Battikhi MN
    Prostate Cancer Prostatic Dis; 2003; 6(3):256-60. PubMed ID: 12970732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hemodialysis on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoglu U
    Scand J Urol Nephrol; 2007; 41(5):382-6. PubMed ID: 17853041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia].
    Gao ZW; Liu G; Sheng BW
    Ai Zheng; 2004 Jun; 23(6):701-3. PubMed ID: 15191675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives.
    Gray MA; Delahunt B; Fowles JR; Weinstein P; Cookes RR; Nacey JN
    Anticancer Res; 2004; 24(3b):2069-72. PubMed ID: 15274402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms.
    Filella X; Truan D; Alcover J; Quintó L; Molina R; Luque P; Coca F; Ballesta AM
    Urology; 2004 Jun; 63(6):1100-3; discussion 1103-4. PubMed ID: 15183958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in prostate disease symptoms and visits to the general practitioner among three ethnic groups in New Zealand.
    Gray MA; Crampton P; Weinstein P; Nacey JN
    BJU Int; 2004 Jul; 94(1):96-100. PubMed ID: 15217439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement and analysis of different serum PSA in patients with benign prostatic hyperplasia].
    Li Y; Xu P; Zhang PA; Su HW; Zhang J
    Zhonghua Nan Ke Xue; 2003 Aug; 9(5):361-3, 366. PubMed ID: 14513646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostatic massage on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoğlu U
    Urology; 2005 Dec; 66(6):1234-8. PubMed ID: 16360449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative value of molecular forms of prostate-specific antigen in diagnosis of prostatic cancer].
    Mazo EB; Sergeeva NA; Grigor'ev ME; Lebedev DV; Solov'eva EV; Konorev VA; Krovets AA
    Urologiia; 2006; (3):21-4. PubMed ID: 16889084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophoretic subforms of free prostate-specific antigen in serum as promising diagnostic tool in prostate cancer diagnostics.
    Jung K; Hoesel W; Reiche J; Deger S; Kramer J; Loening SA; Lein M; Stephan C
    Urology; 2007 Feb; 69(2):320-5. PubMed ID: 17320672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexed PSA in routine diagnosis.
    Oremek GM; Sapoutzis N; Eden F; Jonas D
    Anticancer Res; 2003; 23(2A):975-7. PubMed ID: 12820333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program.
    Barqawi AB; Golden BK; O'Donnell C; Brawer MK; Crawford ED
    Urology; 2005 Apr; 65(4):708-12. PubMed ID: 15833513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of various prostate specific antigen ratios for the early detection of prostate cancer.
    Ozdal OL; Aprikian AG; Bégin LR; Behlouli H; Tanguay S
    BJU Int; 2004 May; 93(7):970-4; discussion 974. PubMed ID: 15142145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSA-related markers in the detection of prostate cancer and high-grade disease in the contemporary era with extended biopsy.
    Bratslavsky G; Fisher HA; Kaufman RP; Voskoboynik D; Nazeer T; Mian BM
    Urol Oncol; 2008; 26(2):166-70. PubMed ID: 18312936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age.
    Sävblom C; Malm J; Giwercman A; Nilsson JA; Berglund G; Lilja H
    Prostate; 2005 Sep; 65(1):66-72. PubMed ID: 15880475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A preliminary study of PSA level in 646 healthy men in Beijing].
    Shao Q; Guo Y; Guo H
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):591-2. PubMed ID: 11798824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic differences and recent trends in coronary heart disease incidence in New Zealand.
    Bell C; Swinburn B; Stewart A; Jackson R; Tukuitonga C; Tipene-Leach D
    N Z Med J; 1996 Mar; 109(1017):66-8. PubMed ID: 8606820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.